The draft legislation, which is set to be made public on Wednesday, was reviewed by The New York Times and confirmed by two E.U. The new rules will make it harder for pharmaceutical companies producing Covid-19 vaccines in the European Union to export them and are likely to disrupt supply to Britain. The European Union has been primarily at loggerheads with AstraZeneca since it drastically cut its supply to the bloc, citing production problems in January, and the company is the main target of the new rules. But the legislation, which could block the export of millions of doses from E.U. Britain is by far the biggest benefactor of E.U.

Source: International New York Times March 24, 2021 01:15 UTC